基本信息
views: 93
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Bob Young is a Professor of Chemistry and the Merck Frosst-British Columbia Leadership Chair in Pharmaceutical Genomics, Bioinformatics and Drug Discovery at Simon Fraser University and the Medicinal Chemistry Division Head at the Centre for Drug Research and Development in Vancouver, Canada. Dr. Young’s research focuses on the design and synthesis of small molecule probes to discover and validate biological drug targets, and the design of enzyme inhibitors, and receptor agonists and antagonists for the treatment of osteoporosis, inflammation, atherosclerosis, diabetes and cancer. Dr. Young is a Fellow of the Royal Society of Canada, a Fellow of the Chemistry Institute of Canada, and past President of the Canadian Society for Pharmaceutical Science. Dr. Young received his PhD from the University of British Columbia, and a DIC from Imperial College London. Before joining the faculty at SFU in 2007, Dr. Young was a Vice President at Merck Frosst in Montreal and acting site head of Merck & Co.’s neuroscience research laboratories at Terlings Park.
Research Interests
Papers共 358 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jimena Perez-Vargas,Liam J. Worrall,Andrea D. Olmstead,Anh-Tien Ton,Jaeyong Lee,Ivan Villanueva,Connor A. H. Thompson, Svenja Dudek,Siobhan Ennis,Jason R. Smith,Tirosh Shapira, Joshua De Guzman,
Medicinal Chemistry Researchno. 7 (2023): 1231-1234
JACS AUno. 11 (2022): 2400-2416
Molecular therapy : the journal of the American Society of Gene Therapyno. 9 (2022): 3034-3051
STAR PROTOCOLSno. 2 (2022): 101258-101258
RSC MEDICINAL CHEMISTRYno. 1 (2021): 43-56
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn